Funding for this research was provided by:
Health Research Council of New Zealand (15/576)
Text and Data Mining valid from 2020-01-02
Received: 30 October 2019
Accepted: 21 December 2019
First Online: 2 January 2020
Compliance with Ethical Standards
: This trial was funded by grants from the Health Research Council of New Zealand. Trial medication was supplied by Novartis. Dr Reid has received honoraria and/or research grants from Amgen, Merck, Lilly and Novartis. Anne M. Horne, Borislav Mihov, Angela Stewart, Sonja Bastin, and Gregory D. Gamble have nothing to disclose.
: The trial was approved by the regional Health and Disability Ethics Committee, and all participants provided written informed consent.